- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01676636
Delivery Vehicles for Prenatal Calcium Supplementation
April 14, 2021 updated by: Stanley Zlotkin, The Hospital for Sick Children
Preference, Acceptability, and Palatability of Alternative Delivery Vehicles for Prenatal Calcium Supplementation Among Pregnant Women in Bangladesh
The SickKids-led research team is currently developing a prenatal micronutrient powder that will contain calcium, iron, and folic acid with different absorption characteristics.
Once the powder is developed, it can be incorporated into various oral delivery vehicles.
The overall effectiveness of a micronutrient program is highly dependent on the acceptance and regular consumption of supplements (i.e., adherence) by the targeted users.
This is a study of the preference, acceptability, and palatability of 4 alternative delivery vehicles for the innovative prenatal multiple micronutrient supplement: traditional tablets, oral disintegrating tablets, unflavoured powder with a suspension agent, and flavoured powder with a suspension agent.
This study will be conducted in Dhaka, Bangladesh.
This study hypothesizes that that the formulation of the delivery vehicle will impact preference, acceptability, and palatability.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
149
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Dhaka, Bangladesh
- International Center for Diarrheal Disease Research
-
-
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women who are between 13 and 30 weeks pregnant.
Participants will be recruited from Shimantik .
Description
Inclusion Criteria:
- Pregnant women ages 18 to < 40 years
- Gestational age of 13-30 completed weeks, estimated based on the recalled first day of the last menstrual period (LMP)
- Current residence in Dhaka at a fixed address
- Plan to remain in Dhaka for the duration of the study
Exclusion Criteria:
- Reported complications of current pregnancy
- Complicated medical or obstetric history that may increase the risk of preterm birth or prenatal complications, based on self-report
- Moderate or severe anaemia (hemoglobin < 90 g/L, accessed with Hemocue)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pregnant Women
Women who are 13 to 30 weeks pregnant.
Each participant will take all 4 different calcium vehicles and decide which one they prefer.
|
The traditional tablets will be swallowed with liquid.
Each tablet will contain 500 mg of calcium (as calcium carbonate), thus participants will be asked to take 3 per day.. Participants will be asked to take the tablets with a liquid of their choosing with a meal.
Traditional tablets will function as a control in this study, as they represent what is widely available on the market in Bangladesh.
Chewable tablets are chewed in the absence of additional water.
Each chewable tablet will contain 300 mg of calcium (as calcium carbonate), thus participants will be asked to take 5 per day.
Participants will be asked to consume the chewable tablets with a meal.
The unflavoured powder with suspension agent will be tasteless and consumed by either adding it to a semi-solid food or drink of one's choosing.
Appropriate foods for mixing with the powder will be at the discretion of the participants.
This vehicle was selected on the basis that it would be easy to swallow, given the nausea associated with pregnancy.
A similar product is Sprinkles, a multiple micronutrient powder developed at SickKids by Dr. Zlotkin.
The flavoured powder with suspension agent will be consumed by adding it to clean water with a meal.
This vehicle was also selected on the basis that it would be easy to swallow, given the nausea associated with pregnancy.
Similar products include oral rehydration salts or artificial juice flavour crystals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of Consumption of the Calcium Vehicle
Time Frame: Change from Baseline in Consumption of the Calcium Vehicle at day 22
|
Consumption of the delivery vehicles will be measured during the once-weekly interactions with the research assistants in two ways: (1) by self-report from study participants; and (2) by counting the number of missing doses from those provided in the weekly supply.
|
Change from Baseline in Consumption of the Calcium Vehicle at day 22
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability
Time Frame: Day 1, Day 9, Day 16, Day 22
|
Measured by colour, preparation, administration.
|
Day 1, Day 9, Day 16, Day 22
|
|
Ease of Use
Time Frame: Day 1, Day 9, Day 16, Day 22
|
Measured by size and ease of swallowing.
|
Day 1, Day 9, Day 16, Day 22
|
|
Patibility
Time Frame: Day 1, Day 9, Day 16, Day 22
|
Measured by taste, texture, aftertaste, and odour.
|
Day 1, Day 9, Day 16, Day 22
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Daniel Roth, MD, The Hospital for Sick Children
- Principal Investigator: Stanley Zlotkin, MD, The Hospital for Sick Children
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Actual)
March 1, 2013
Study Completion (Actual)
March 1, 2013
Study Registration Dates
First Submitted
August 16, 2012
First Submitted That Met QC Criteria
August 30, 2012
First Posted (Estimate)
August 31, 2012
Study Record Updates
Last Update Posted (Actual)
April 19, 2021
Last Update Submitted That Met QC Criteria
April 14, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1000032744
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Kafrelsheikh UniversityNot yet recruitingEctopic PregnancyEgypt
-
Meir Medical CenterRecruiting
-
Bagcilar Training and Research HospitalRecruitingEctopic PregnancyTurkey (Türkiye)
-
MELISA Institute Genomics & Proteomics Research...RecruitingHealthy | Pregnancy | Early Pregnancy | Early Pregnancy Loss | ChildbirthChile
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
Zagazig UniversityCompleted
Clinical Trials on Traditional Tablet
-
Omni MedUnknownTelemedicine | Community Health ServicesUnited States, Uganda
-
University of South FloridaNot yet recruiting
-
University of TalcaAgencia Nacional de Investigación y DesarrolloCompleted
-
University of KarachiHunan Xinhui Pharmacy Limited CompanyCompleted
-
Peking University Third HospitalNot yet recruiting
-
IRCCS San RaffaeleCompleted
-
Peking Union Medical College HospitalGuangdong Provincial Hospital of Traditional Chinese Medicine; Peking University... and other collaboratorsRecruitingFunctional Hypothalamic AmenorrheaChina
-
Henan University of Traditional Chinese MedicineThe First Affiliated Hospital of Zhengzhou University; China-Japan Friendship... and other collaboratorsNot yet recruiting
-
Peking Union Medical College HospitalShandong University; Guangdong Provincial Hospital of Traditional Chinese Medicine and other collaboratorsNot yet recruitingInfertility | Diminished Ovarian Reserve (DOR)China
-
Qianfoshan HospitalNot yet recruitingHepatic Encephalopathy | Cirrhosis, Liver | Portosystemic ShuntChina